28th Sep 2007 15:05
GlaxoSmithKline PLC28 September 2007 GLAXOSMITHKLINE PLC ANNOUNCES CHANGE TO THE BOARD OF DIRECTORS GlaxoSmithKline plc (GSK) announces that Professor Sir Roy Anderson has beenappointed a Non-Executive Director and will join the Board of the Company witheffect from 1st October 2007. Professor Anderson is Professor of Infectious Disease Epidemiology, ImperialCollege, London and, until 30 September 2007, Chief Scientific Advisor to theUK's Ministry of Defence. In commenting on his appointment, Sir Christopher Gent, Chairman of GSK, said: "I am delighted that Professor Anderson has agreed to join the Board. Inaddition to fulfilling the usual responsibilities of a Non-Executive Director,he will spend time within our research and development organisation and, withhis experience, will provide the Board with valuable insights to scientificdevelopments outside GSK." Professor Anderson's biographical details are given below together with a tableshowing the membership of the Board with effect from 1st October 2007. Simon BicknellCompany Secretary 28th September 2007 NOTES The Board has determined that Professor Anderson is independent in accordancewith the Combined Code on Corporate Governance. BIOGRAPHICAL DETAILS Professor Sir Roy Anderson Age 60. Professor Anderson is the Professor of Infectious Disease Epidemiologyin the Faculty of Medicine, Imperial College, London and, until 30 September2007, the Chief Scientific Adviser at the Ministry of Defence in the UnitedKingdom. It was announced on 21 June 2007 that Professor Anderson will succeedSir Richard Sykes as Rector of Imperial College in the summer of 2008. He is a Fellow of the Royal Society, a Fellow of the Academy of MedicalSciences, a Fellow of the Royal Statistical Society, Honorary Fellow of theInstitute of Actuaries and a Foreign Associate Member of the Institute ofMedicine at the US National Academy of Sciences. He has published over 450 scientific papers on the epidemiology, populationbiology, evolution and control of a wide variety of infectious disease agents,including HIV, BSE, vCJD, parasitic helminths and protozoa, and respiratorytract viral and bacterial infections. His principal research interests are epidemiology, biomathematics, demography,parasitology, immunology and health economics. He also has a keen interest inscience policy and the public understanding of science. He received a Knighthood in the Queen's Birthday Honours in June 2006. BOARD MEMBERSHIP WITH EFFECT FROM 1ST OCTOBER 2007 Sir Christopher Gent ChairmanSir Ian Prosser Senior Independent Non-Executive Director Dr J-P Garnier Chief Executive OfficerMr J S Heslop Chief Financial OfficerDr Moncef Slaoui Executive Director, Chairman, Research & Development Professor Sir Roy Anderson Independent Non-Executive DirectorDr Stephanie Burns Independent Non-Executive DirectorMr H Lawrence Culp Independent Non-Executive DirectorSir Crispin Davis Independent Non-Executive DirectorSir Deryck Maughan Independent Non-Executive DirectorDr Daniel Podolsky Independent Non-Executive DirectorDr Ronaldo Schmitz Independent Non-Executive DirectorMr Tom De Swaan Independent Non Executive DirectorSir Robert Wilson Independent Non-Executive Director Enquiries: UK Media enquiries: Philip Thomson (020) 8047 5502 Alice Hunt (020) 8047 5502 Joss Mathieson (020) 8047 5502 Claire Brough (020) 8047 5502 US Media enquiries: Nancy Pekarek (215) 751 7709 Mary Anne Rhyne (919) 483 2839 European Analyst/Investor enquiries: David Mawdsley (020) 8047 5564 Sally Ferguson (020) 8047 5543 US Analyst/ Investor enquiries: Frank Murdolo (215) 751 7002 Tom Curry (215) 751 5419 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline